Journal list Promote Sponsor
verified SJR 1,174 · Q1 • database Scopus / SJR & Web of Science indexed
Current Opinion in Infectious Diseases
United States · Lippincott Williams and Wilk...
workspace_premium Q1 — Infectious Diseases lock Subscription

Current Opinion in Infectious Diseases

Current Opinion in Infectious Diseases is a journal indexed in SJR in Infectious Diseases and Microbiology (medical) with an H index of 122. It has an SJR impact factor of 1,174 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,174.

Current Opinion in Infectious Diseases focuses its scope in these topics and keywords: inhibitors, skin, soft, reverse, therapy, tissue, hepatitis, nucleoside, coinfection, toxicity, ...

ISSN: 1473-6527
Publisher: Lippincott Williams and Wilkins
Category: Infectious Diseases
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,174 Q1
H-index 122
Acceptance rate pie_chart
24% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,174

H-index

122

Docs (year)

89

Docs 3y

264

Total refs

5377

Cites 3y

954

Citable 3y

250

Cites/Doc 2y

3.85

Ref/Doc

60.42

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs